WOONSOCKET, R.I. , Dec. 16, 2024 /PRNewswire/ -- CVS Health Corporation ("CVS Health" or the "Company," NYSE: CVS) announced today the applicable Reference Yields and Total Consideration (each as summarized in the tables below) to be paid in connection with the previously announced cash tender offer (the "Maximum Tender Offer" ) for the maximum principal amount of the following series of Maximum Tender Offer Notes (as defined below) for which the aggregate purchase price, not including Accrued Interest (as defined below), payable in respect of such Maximum Tender Offer Notes, does not exceed $1,774,423,242.62 (such maximum purchase price, the "Maximum Tender Offer Amount"): its 2.700% Senior Notes due 2040, the 3.875% Senior Notes due 2047 issued by its wholly-owned subsidiary Aetna Inc. ("Aetna"), its 4.250% Senior Notes due 2050, the 4.125% Senior Notes due 2042 issued by Aetna, its 4.125% Senior Notes due 2040, its 2.125% Senior Notes due 2031, its 1.875% Senior Notes due 2031, its 5.050% Senior Notes due 2048, the 4.500% Senior Notes due 2042 issued by Aetna and its 1.750% Senior Notes due 2030 (together, the "Maximum Tender Offer Notes"). The applicable Reference Yield for the Maximum Tender Offer Notes and the Total Consideration for the Maximum Tender Offer Notes are summarized in the table below: Maximum Tender Offer Notes : Title of Notes CUSIP Number Original Issuer Principal Amount Outstanding Maturity Date Acceptance Priority Level (1) UST Reference Security Bloomberg Reference Page Fixed Spread (bps) Early Tender Payment (2) Reference Yield (3) Total Consideration (2)(3) Approximate Proration Factor (4) 2.700% Senior Notes due 2040 126650DP2 CVS Health Corporation $1,250,000,000 8/21/2040 1 4.625% due 11/15/2044 FIT1 +110 bps $30 4.676 % $685.54 100 % 3.875% Senior Notes due 2047 00817YAZ1 Aetna Inc. $1,000,000,000 8/15/2047 2 4.625% due 11/15/2044 FIT1 +121 bps $30 4.676 % $750.06 100 % 4.250% Senior Notes due 2050 126650DL1 CVS Health Corporation $750,000,000 4/1/2050 3 4.250% due 8/15/2054 FIT1 +136 bps $30 4.611 % $776.80 100 % 4.125% Senior Notes due 2042 00817YAM0 Aetna Inc. $500,000,000 11/15/2042 4 4.625% due 11/15/2044 FIT1 +122 bps $30 4.676 % $805.69 100 % 4.125% Senior Notes due 2040 126650DK3 CVS Health Corporation $1,000,000,000 4/1/2040 5 4.625% due 11/15/2044 FIT1 +119 bps $30 4.676 % $825.77 57.5 % 2.125% Senior Notes due 2031 126650DR8 CVS Health Corporation $1,000,000,000 9/15/2031 6 4.250% due 11/15/2034 FIT1 +92 bps $30 N/A N/A 0 % 1.875% Senior Notes due 2031 126650DQ0 CVS Health Corporation $1,250,000,000 2/28/2031 7 4.250% due 11/15/2034 FIT1 +87 bps $30 N/A N/A 0 % 5.050% Senior Notes due 2048 126650CZ1 CVS Health Corporation $8,000,000,000 3/25/2048 8 4.250% due 8/15/2054 FIT1 +156 bps $30 N/A N/A 0 % 4.500% Senior Notes due 2042 00817YAJ7 Aetna Inc. $500,000,000 5/15/2042 9 4.625% due 11/15/2044 FIT1 +130 bps $30 N/A N/A 0 % 1.750% Senior Notes due 2030 126650DN7 CVS Health Corporation $1,250,000,000 8/21/2030 10 4.125% due 11/30/2029 FIT1 +106 bps $30 N/A N/A 0 % (1) Subject to each of the Maximum Tender Offer Amount and proration, the principal amount of each series of Maximum Tender Offer Notes that is purchased in the Maximum Tender Offer will be determined in accordance with the applicable acceptance priority level (in numerical priority order) specified in this column. (2) Per $1,000 principal amount of Maximum Tender Offer Notes validly tendered at or prior to the Early Tender Date (as defined below) and accepted for purchase. (3) Pricing information has only been provided for the Maximum Tender Offer Notes that are expected to be fully or partially accepted for tender. (4) The proration factor has been rounded to the nearest tenth of a percentage point for presentation purposes. The Maximum Tender Offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 2, 2024 (as it may be amended or supplemented from time to time, the "Offer to Purchase"), which sets forth a more detailed description of the Maximum Tender Offer. Copies of the Offer to Purchase are available at www.dfking.com/cvs . The Maximum Tender Offer is open to all registered holders (individually, a "Holder" and collectively, the "Holders") of the Maximum Tender Offer Notes. The Total Consideration payable by CVS Health for the Maximum Tender Offer Notes is a price per $1,000 principal amount calculated as described in the Offer to Purchase in a manner intended to result in a yield to maturity or first par call date, as the case may be, equal to the sum of the yield to maturity of the applicable U.S. Treasury reference security specified in the table above as determined at 10:00 a.m. , New York City time, on December 16, 2024 and the applicable fixed spread shown in the table above. Maximum Tender Offer Notes that were tendered and not validly withdrawn at or prior to 5:00 p.m. , New York City time, on December 13, 2024 (the "Early Tender Date") and that are accepted for purchase will receive the applicable Total Consideration, which includes the Early Tender Payment (as defined in the Offer to Purchase). Maximum Tender Offer Notes that are tendered after the Early Tender Date but at or prior to 5:00 p.m. , New York City time, on December 31, 2024 (the "Maximum Tender Offer Expiration Date") (unless earlier terminated by CVS Health as described in the Offer to Purchase) and that are not validly withdrawn and that are accepted for purchase will receive only the applicable Tender Offer Consideration (as defined in the Offer to Purchase), which is the applicable Total Consideration minus the Early Tender Payment. The Maximum Tender Offer Withdrawal Deadline of 5:00 p.m. , New York City time, on December 13, 2024 has passed and, accordingly, Maximum Tender Offer Notes validly tendered in the Maximum Tender Offer may no longer be withdrawn. The settlement date for the Maximum Tender Offer Notes validly tendered at or prior to the Early Tender Date and accepted for purchase is expected to be December 18, 2024 , the third business day after the Early Tender Date (the "Early Settlement Date"). Although the Maximum Tender Offers is scheduled to expire at 5:00 p.m. , New York City time, on December 31, 2024 , unless extended or terminated, because the aggregate purchase price of Notes validly tendered (and not validly withdrawn) prior to the Early Tender Date exceeded the Maximum Tender Offer Amount, there is not expected to be a Final Settlement Date (as defined in the Offer to Purchase), and no Notes tendered after the Early Tender Date are expected to be accepted for purchase. In addition to the Total Consideration for the Maximum Tender Offer Notes, Holders of the Maximum Tender Offer Notes accepted for purchase on the Early Settlement Date will receive accrued and unpaid interest ("Accrued Interest") on those Maximum Tender Offer Notes from the last interest payment date with respect to those Maximum Tender Offer Notes to, but not including, the Early Settlement Date. CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to amend, extend or terminate the Maximum Tender Offer with respect to any or all series of Maximum Tender Offer Notes at any time if any condition to the Maximum Tender Offer is not satisfied. The Maximum Tender Offer is not conditioned on any minimum principal amount of Maximum Tender Offer Notes being tendered but the Maximum Tender Offer is subject to certain other general conditions as described in the Offer to Purchase. CVS Health has retained Barclays Capital Inc. and Mizuho Securities USA LLC to act as Dealer Managers for the Maximum Tender Offer. D.F. King & Co., Inc. has been retained to act as the Tender and Information Agent for the Maximum Tender Offer. The Offer to Purchase may be accessed at the following link: http://www.dfking.com/cvs . Requests for assistance relating to the procedures for tendering Maximum Tender Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com , or by phone (212) 269-5550 (for banks and brokers only) or (800) 487-4870 (for all others toll free). Requests for assistance relating to the terms and conditions of the Maximum Tender Offer may be directed to Barclays Capital Inc. at (800) 438-3242 (toll free) or (212) 528-7581 (collect) or Mizuho Securities USA LLC at (866) 271-7403 (toll-free) or (212) 205-7741. Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance. This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, any securities, including the Maximum Tender Offer Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Maximum Tender Offer is being made solely pursuant to the Offer to Purchase made available to Holders of the Maximum Tender Offer Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Maximum Tender Offer Notes, or any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Maximum Tender Offer Notes in response to the Maximum Tender Offer. Holders are urged to evaluate carefully all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Maximum Tender Offer Notes in the Maximum Tender Offer, and, if so, the principal amount of Maximum Tender Offer Notes to tender. About CVS Health CVS Health is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of September 30, 2024 , the Company had more than 9,000 retail locations, more than 900 walk-in medical clinics, more than 225 primary care medical clinics, a leading pharmacy benefits manager with approximately 90 million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 36 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs. Forward-Looking Statements This press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2024 , June 30, 2024 and September 30, 2024 and our Current Reports on Form 8-K. You are cautioned not to place undue reliance on CVS Health's forward-looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. Investor Larry McGrath Media Ethan Slavin Contact: Executive Vice President Contact: 860-273-6095 Chief Strategy Officer & Chief Strategic Advisor to the CEO investorinfo@cvshealth.com Ethan.Slavin@CVSHealth.com View original content to download multimedia: https://www.prnewswire.com/news-releases/cvs-health-corporation-announces-pricing-of-maximum-tender-offer-302333016.html SOURCE CVS HealthThe addition of windshields to electric scooters is intended to provide protection from wind, rain, and debris while driving. However, reports have surfaced indicating that the use of windshields on electric scooters may pose a safety risk, particularly in the event of a crash or collision.
In conclusion, Arsenal's struggles in front of goal are a cause for concern, as they indicate a broader problem with the team's attacking play and creativity. With the Premier League becoming increasingly competitive and demanding, Arsenal must address these issues if they are to compete at the highest level. By improving their attacking efficiency and versatility, Arsenal can unlock their full potential and achieve success on the field. Only time will tell whether Mikel Arteta and his team can rise to the challenge and overcome their offensive woes.Moreover, Tencent Video has improved its streaming quality and user interface to offer a seamless and enjoyable viewing experience. Subscribers can now enjoy high-definition video streaming with faster loading times and smoother playback, enhancing their overall experience on the platform.The No. 2 Ohio State Buckeyes handed the No. 5 Indiana Hoosiers their first loss of the season Saturday, securing a 38-15 victory at Ohio Stadium in Columbus. By virtue of the win, OSU improved to 10-1 overall and 7-1 in conference play, meaning it controls its own destiny in terms of reaching the Big Ten Championship Game for a potential rematch with the No. 1 Oregon Ducks. The Hoosiers have the same record as the Buckeyes at 10-1 overall and 7-1 in conference play, but given how thoroughly outclassed they were on Saturday, several fans and analysts took to X to consider the possibility of IU missing out on the College Football Playoff: Special teams was perhaps the biggest difference maker in Saturday's game, as a pair of huge plays helped the Buckeyes go from tied 7-7 to up 21-7. With less than two minutes remaining in the first half, a snap went through Indiana punter James Evans' hands, allowing Ohio State to start the drive at Indiana's 7-yard line: OSU cashed in with a four-yard rushing touchdown by TreVeyon Henderson to take a 14-7 lead into halftime: The Hoosiers' first offensive drive of the second half was a three-and-out, and the ensuing punt was another disaster, as Ohio State safety Caleb Downs returned it 79 yards for a touchdown to extend the lead to 21-7: The Ohio State defense forced another three-and-out on Indiana's next drive, and the OSU offense essentially put the game out of reach after that, grinding out a 10-play, 75-yard drive, culminating in a one-yard touchdown pass from quarterback Will Howard to tight end Jelani Thurman to extend the lead to 28-7: In addition to the impact plays on special teams, Ohio State was dominant defensively, allowing just 151 total yards. Indiana quarterback Kurtis Rourke entered Saturday's contest with an outside shot at the Heisman Trophy, but he is likely now out of the running completely after the Buckeyes limited him to 68 passing yards and no touchdowns on 8-for-18 passing. Ohio State's offense was more methodical than explosive Saturday, but there was still some solid production to speak of, as quarterback Will Howard went 22-of-26 for 201 yards with two touchdowns and one interception, plus a rushing score, and wide receivers Emeka Egbuka and Carnell Tate had seven receptions for 80 yards and a touchdown, and four catches for 68 yards, respectively. After the Buckeyes cemented their status as the No. 2 team in the nation Saturday, social media chatter focused on their strong play and the likely rematch with Oregon in the Big Ten Championship Game: While many are now questioning whether Indiana should have been a top-five team based on how it performed Saturday, OSU now has two top-five wins to its credit, beating the No. 5 Hoosiers and the then-No. 3 Penn State Nittany Lions. The Buckeyes also lost to now-No. 1 Oregon by only one point on the road, suggesting that they are undoubtedly national title contenders. Assuming Ohio State takes care of business at home against struggling rival Michigan next weekend, it will likely face Oregon again in the Big Ten Championship Game with the winner earning a first-round bye in the CFP and quite possibly the No. 1 seed. As for the Hoosiers, they will host 1-10 Purdue next weekend, and in addition to undoubtedly needing a win to remain in the CFP picture, they may have to blow out the Boilermakers to have a shot at their first-ever CFP berth.
I’m a hot gran & get paid to be sexy Santa – trolls tell me to cover up but this way I can spend more time with family
Myth #1: Pneumonia Requires Immediate Antibiotics
Since his appointment as the Senior White House Policy Advisor for US President-elect Donald Trump, Sriram Krishnan, an Indian-origin entrepreneur, has sparked significant debate. His views on immigration and green card limits have faced widespread criticism. However, despite the controversy, Elon Musk, one of the wealthiest individuals globally and a renowned tech visionary, has voiced his support for Krishnan. Washington: Since Sriram Krishnan, an Indian-origin entrepreneur, was announced as the Senior White House Policy Advisor for US President-elect Donald Trump, he has become a topic of intense discussion. Many have criticised his stance on immigration and green card limits. Despite the backlash, Elon Musk, widely regarded as one of the world’s richest persons and a visionary tech entrepreneur, has came in support for Krishnan. Amid the criticism, a user on X shared a post featuring a photo of butter chicken alongside an image of Sriram Krishnan. The caption read, “ Here is what Sriram Krishnan would look like if he was butter chicken.” The butter chicken image appears to be AI-generated, covering Krishnan’s face and neck with the dish. David Sacks, Donald Trump’s newly appointed head of artificial intelligence (AI) and cryptocurrency, stepped in to clarify Krishnan’s stance. He responded, “Point of clarification: Sriram didn’t say he wants to remove all caps on green cards. He said he wants to remove country caps on green cards...” Elon Musk agreed with Sacks’ explanation, He replied, “Makes sense.” Click for more latest World news . Also get top headlines and latest news from India and around the world at News9. Adan Khan is an emerging journalist with a keen focus on crime and politics. With a talent for making complex issues accessible, he has quickly become known for his ability to clarify intricate topics. Now with a year of experience in the news industry, Adan remains committed to delivering the truth, regardless of its difficulty. His writing seeks to make critical subjects both clear and engaging, offering readers insightful perspectives and guiding them through challenging issues. Dedicated to continuous growth, Adan is here to inform, engage, and make a meaningful impact in journalism."I want to set the record straight and clarify that I am not dating anyone at the moment," Xuan Xuan stated firmly. "I appreciate the support and love from my fans, but I also ask for understanding and respect for my personal boundaries."
11. Tom Cleverley - Once touted as a promising talent, Cleverley's career trajectory took a different path after leaving United in 2015. He now represents Watford in the English Championship.None
The U.S. National Telecommunications and Information Administration (NTIA) issued a seeking public input on the potential writing of ethical guidelines to address ethical concerns involving the use of “pervasive data” in research. NTIA is seeking public input to determine whether non-binding ethical guidelines should be crafted to guide researchers in navigating these challenges responsibly. Pervasive data captures intimate details about individuals from their browsing behaviors to their social media interactions. While this data holds immense potential for advancing societal understanding and technological innovation, it also poses risks to and individual rights. NTIA said “such guidelines, if warranted, would detail how researchers can work with pervasive data while meeting ethical expectations of research and protecting individuals’ privacy and other rights. These guidelines, although voluntary, would serve as a crucial reference for researchers, institutions, data intermediaries, and online service providers. They would seek to bridge the gap between existing legal regulations, such as the Common Rule, and the unique ethical dilemmas posed by pervasive data. NTIA says pervasive data has become a cornerstone of contemporary research, offering insights into human behavior, societal dynamics, and the digital ecosystem. “These insights are essential for informing policy in the digital age, and researchers and organizations have called for ethical guidelines to help ensure this work is done responsibly,” NTIA said, noting, however, that this data is often collected without explicit consent, raising questions about how it can be used ethically in research while respecting individuals’ privacy and autonomy. “NTIA will rely on these comments, along with engagements with researchers, civil society, research institutions, industry, and other government bodies, to consider whether to draft and issue guidelines to assist researchers working with pervasive data,” the agency said. “The ethical guidelines outlined for consideration in this Request for Comments would be non-binding and would not supersede any existing laws or regulations or pre-empt future laws. For example, human subjects research conducted or supported by one of the U.S. government departments or agencies that have adopted the Federal Policy for the Protection of Human Subjects would need to adhere to any applicable regulatory requirements. Federal agencies and federal data are bound by additional laws and regulations, which these voluntary ethical guidelines would not supersede.” NTIA’s efforts are underscored by the limitations of existing ethical frameworks. For example, , commissioned in 1979 by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, laid the groundwork for ethical research in the United States by introducing principles such as respect for persons, beneficence, and justice. These principles informed the Common Rule, which regulates federally funded human subjects research. However, the Common Rule’s applicability to pervasive data is limited. It primarily governs research involving identifiable private information obtained through direct interaction or intervention, leaving significant gaps in addressing the broader societal risks posed by pervasive data. Moreover, certain types of research using pervasive data may fall outside the Common Rule’s jurisdiction. For instance, NTIA pointed out, studies involving anonymized or publicly available data often bypass institutional review board oversight. Yet, even anonymized data carries the risk of , potentially exposing individuals to harm. These gaps highlight the need for updated ethical guidelines that reflect the nuances of pervasive data in research. Internationally, the ethical use of pervasive data is gaining attention. The European Union’s Digital Services Act, for example, mandates that large online platforms share data with researchers to study systemic risks in the information environment. While this approach facilitates transparency, it also underscores the importance of robust ethical standards to protect individuals and uphold trust in the research process. NTIA’s proposed guidelines could align U.S. practices with global standards, fostering international collaboration and ensuring that research is conducted with a shared commitment to ethical principles. One of the most pressing concerns in research involving pervasive data is the risk to privacy, NTIA said, pointing out that online platforms collect vast amounts of data, often without users fully understanding how it will be used, creating tension between the potential benefits of research and the right of individuals to control their personal information. Privacy risks extend beyond reidentification; they also include emotional distress, reputational harm, and the perpetuation of discrimination. Additionally, misuse of pervasive data can erode public trust in research, deterring individuals from engaging in the digital economy or participating in studies. NTIA’s proposed guidelines would address these risks by promoting transparency, accountability, and informed consent. Researchers would be encouraged to consider the potential for harm at every stage of their projects, from data collection to dissemination. This proactive approach aligns with the principles of the which builds on the by emphasizing respect for law and public interest in network and security research. By adopting similar principles, NTIA would be ensuring that ethical considerations remain central to research involving pervasive data. Another critical issue is the potential for systemic risks. Research using pervasive data can unintentionally exacerbate societal inequalities or contribute to harmful technologies. For example, algorithms trained on biased data may perpetuate discrimination, while the misuse of research findings can undermine trust in institutions. Ethical guidelines must therefore extend beyond individual-level risks to address the broader implications of pervasive data research. This includes considering the environmental impact of data processing and the unintended consequences of machine learning models. NTIA’s initiative also recognizes the importance of fostering a culture of ethical awareness among researchers. While many researchers already take voluntary measures to mitigate risks, the absence of a unified set of guidelines can lead to inconsistencies. The proposed guidelines would provide a benchmark for ethical research, encouraging adherence to best practices across disciplines and institutions. Public engagement is a cornerstone of NTIA’s approach. By soliciting input from diverse stakeholders, including researchers, civil society organizations, industry representatives, and government bodies, NTIA aims to ensure that the guidelines are comprehensive and reflective of varied perspectives. This participatory process is essential for addressing the complex ethical challenges posed by pervasive data. NTIA’s effort to draft ethical guidelines for pervasive data research marks a significant step in balancing innovation with privacy and ethical integrity. As pervasive data continues to shape our understanding of the digital world, it is imperative to establish standards that protect individuals while enabling responsible research. The proposed guidelines have the potential to set a precedent for ethical practices, fostering trust and ensuring that the benefits of research are realized without compromising fundamental rights. NTIA’s initiative underscores the need for a thoughtful and collaborative approach to pervasive data. By prioritizing privacy and ethical responsibility, these guidelines can serve as a roadmap for navigating the complex intersection of technology, research, and human rights in the digital age. As public input shapes the development of these guidelines, NTIA has an opportunity to lead the way in defining ethical standards for the responsible use of pervasive data. | | | | | | | | |2. Inter Milan:Tulane QB Mensah transfers to Duke
Russian Media: Bashar al-Assad Arrives in Moscow, Receives Russian Protection Igniting Changes in the SituationA SELF-PROCLAIMED hot gran has revealed that she has been able to spend more time with her family this Christmas, after being paid to dress up as sexy Santa. Jessika Rains, 41, spent 20 years as a nurse before ditching her career to earn five times more stripping off. The mum of four loves dressing up in racy outfits for her job, and said the best part is that she gets to spend more time with her grandkids. And during the festive period, Jessika has loved making cash by dressing up as a sexy Santa and a naughty elf. Jessika first entered the industry back in 2020, during the pandemic, and balanced both of her careers before quitting nursing for good in 2022. She now has over a million followers across her social media platforms, all desperate to see her content. Jessika said that she loves satisfying her customers but only makes content she is comfortable with. "I'm trying to please you but at the same time I'm trying to respect my feelings on situations and create genuine content that's going to come off that I'm enjoying it too", she told the Daily Star. "I need some type of self-reward. "So if it's something I haven't done, and I'm curious to see if it's going to pleasure me, then I will perform it. "But if I know that it's just not in my wheelhouse, or not something that I'm going to connect with, I just decline the requests." Discussing her favourite parts of the job, she said: "I like to dirty talk, I'm a dirty talker." Jessika also loves dressing up, stating: "When it comes to dressing up, it's great because in October costumes were my content. "In November someone actually asked for bride content, and I didn't have bride content." Jumping at the chance to film more content, Jessika made some solo bride content, and also got her husband involved, as he got frisky with the "maid of honour." "I did a strip tease for my girlfriend," she added. There are a number of habits you can take up to care for your health and wellbeing as you age. Age UK shared the following tips: In this scenario, her friend put on a veil and things escalated after the strip tease. "So just cute little role-play things. It's just a scenario really", she said. Another theme that has cropped up in her content is sleeping with her husband's best friend. "It's just all that taboo stuff", she said.
First dog-friendly cruise scheduled for 2025. Organizers hope it turns into a recurring event.